Compression Coating Technique and its Formulation in Circadian Rhythm Activity with Chronotherapeutic Drug Delivery System
Open Access
- 28 July 2022
- journal article
- research article
- Published by EManuscript Technologies in International Journal of Pharmaceutical Investigation
- Vol. 12 (3), 323-327
- https://doi.org/10.5530/ijpi.2022.3.54
Abstract
Background: Circadian rhythms is a natural process that regulates the sleep wake cycle which is associated with several physiological, biochemical, endocrine, behavioural processes in humans and entrainment to light-dark cycle. The activity of Ramelteon is believed to contribute to its sleep-promoting properties and thought to be involved in the maintenance of the circadian rhythm underlying the normal sleep-wake cycle. A tablet can be given before 2 hr of bed time, so the Ramelteon drug shows its effect throughout the night by releasing the active content with lag time followed by sustained action to promote the sleep. Materials and Methods: Chronotherapeutic drug delivery system were prepared by compression coating technology using pH independent, hydrophilic and hydrophobic polymers. Results: Drug excipient compatibility indicated that the Ramelteon Active pharmaceutical ingredient (API) is compatibility with the excipients proposed. The X-ray Diffraction (XRD) studies indicated that the crystalline form of the Ramelteon API existed in the finished formulation. Conclusion: The core tablets containing Eudragit RSPO 10mg/tablet and ratio of Ethyl cellulose: Hydroxy propyl methyl cellulose (HPMC) of 70:30 in the outer coating material yielded a desired lag time of 2 hr and drug release for a period of 4 hr to achieve a chronotherapeutic drug delivery system. Ramelteon is an excellent candidate in designing chronotherapeutic drug delivery systems and further in vivo studies can be explored in the treatment of circadian rhythm with sleep wake cycle disorders.Keywords
This publication has 6 references indexed in Scilit:
- Systems ChronotherapeuticsPharmacological Reviews, 2017
- Development of orally disintegrating tablets comprising controlled-release multiparticulate beadsDrug Development and Industrial Pharmacy, 2012
- Oral pulsatile delivery: Rationale and chronopharmaceutical formulationsInternational Journal of Pharmaceutics, 2010
- Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymersPharmaceutical Development and Technology, 2010
- Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performancesEuropean Journal of Pharmaceutical Sciences, 2004
- Development of pulsatile release tablets with swelling and rupturable layersJournal of Controlled Release, 2004